VANCOUVER, British Columbia, Dec. 01, 2017 -- Cameo Resources Corp. (TSX-V:CRU) (OTC:SIDNF) (the “Company”) is pleased to announce the appointment of Mr. Lucas Birdsall to the Company’s board of directors. Mr. Birdsall is an alumnus of the Beedie School of Business at Simon Fraser University, achieving concentrations in the Finance and Operations Management streams. He is presently engaged as a Corporate Communications and Investor Relations Consultant in Vancouver, British Columbia, is a director of Express Capital Corp., and is a senior officer and director of Viena Capital Corp. He was previously an account executive for a leading IT consulting firm, managing enterprise accounts in both the healthcare and transportation verticals, and also recently directed corporate business development at NetCents Technology Inc.
Akash Patel, the Company’s President, said, “Adding Lucas to the board will facilitate the Company’s renewed focus on enhancing shareholder value through acquiring, exploring and developing prospective but undervalued mineral projects.”
The Company has granted 300,000 stock options to certain directors, offices and consultants, with each option exercisable at $1.00 for five years from the date of grant and vesting immediately. The option grant is subject to the provisions of the Company’s stock option plan, the policies of the TSX Venture Exchange and applicable securities laws.
The Company has also accepted the resignation of Mr. Lorne Warner, who has left the Company to focus on other opportunities. The board thanks Lorne for his past efforts and contributions to the Company and wishes him the best of luck with his future endeavours.
On behalf of the board of directors,
CAMEO RESOURCES CORP.
“Akash Patel”
Akash Patel
President
For further information, please contact
Akash Patel
President
604-446-6440
Email: [email protected]
www.cameoresources.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Washington Post Publisher Will Lewis Steps Down After Layoffs
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Anta Sports Expands Global Footprint With Strategic Puma Stake
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 



